These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2831560)

  • 1. Tc-99m DMSA scintigraphy on patients with medullary thyroid carcinoma.
    Groth P; Unterspann S; Schwähn D; Stoll I; Reincke R
    Radiobiol Radiother (Berl); 1987; 28(5):642-4. PubMed ID: 2831560
    [No Abstract]   [Full Text] [Related]  

  • 2. More on [99mTc](V)DMSA scintigraphy in patients with medullary carcinoma of the thyroid.
    Mojiminiyi OA; Udelsman R; Shepstone BJ; Dudley NE; Soper ND
    J Nucl Med; 1989 Aug; 30(8):1420. PubMed ID: 2547036
    [No Abstract]   [Full Text] [Related]  

  • 3. Imaging with pentavalent [99mTc]DMSA in patients with medullary cancer of the thyroid.
    Hilditch TE; Murray T; Connell JM; McLellan AR; Reed NS
    J Nucl Med; 1988 Oct; 29(10):1746-7. PubMed ID: 2845025
    [No Abstract]   [Full Text] [Related]  

  • 4. Positive scintigraphy of medullary thyroid cancer using 201Tl and alkalized 99mTc-DMSA.
    Holub V; Nĕmec J; Neradilová M; Benová M; Blazek T; Dusek M
    Radiobiol Radiother (Berl); 1987; 28(5):640-2. PubMed ID: 2831559
    [No Abstract]   [Full Text] [Related]  

  • 5. Technetium-99m(V)-DMSA in the imaging of medullary thyroid carcinoma.
    J Nucl Med; 1987 Feb; 28(2):252-3. PubMed ID: 3027281
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid.
    Clarke SE; Lazarus C; Mistry R; Maisey MN
    Br J Radiol; 1987 Nov; 60(719):1089-92. PubMed ID: 2825895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of 99mTc(V)DMSA as imaging for the medullary thyroid carcinoma (MTC).
    Guerra U; Pizzocaro C; Terzi A; Giubbini R; Bestagno M
    J Nucl Med Allied Sci; 1988; 32(4):242-7. PubMed ID: 2852709
    [No Abstract]   [Full Text] [Related]  

  • 8. [Scintigraphy of medullary carcinoma of the thyroid by new radiopharmaceuticals].
    Tada J; Konishi J; Torizuka K; Makimoto K; Miyauchi A
    Rinsho Hoshasen; 1984 Sep; 29(9):1043-4. PubMed ID: 6096600
    [No Abstract]   [Full Text] [Related]  

  • 9. Radionuclide imaging in medullary thyroid carcinoma: evaluation of two new radiopharmaceuticals.
    Clarke SE; Lazarus CR; Maisey MN
    Henry Ford Hosp Med J; 1987; 35(2-3):124-6. PubMed ID: 2826368
    [No Abstract]   [Full Text] [Related]  

  • 10. Technetium-99m pentavalent DMSA imaging detects metastases of poorly differentiated carcinoma of the thyroid.
    Costa DC; Glynne-Jones R; Falzon M; Lui D; Ryder JP; Ell PJ
    Clin Nucl Med; 1989 Mar; 14(3):218-21. PubMed ID: 2544341
    [No Abstract]   [Full Text] [Related]  

  • 11. A new imaging agent for medullary carcinoma of the thyroid.
    Ohta H; Yamamoto K; Endo K; Mori T; Hamanaka D; Shimazu A; Ikekubo K; Makimoto K; Iida Y; Konishi J
    J Nucl Med; 1984 Mar; 25(3):323-5. PubMed ID: 6321700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
    Clarke SE; Lazarus CR; Wraight P; Sampson C; Maisey MN
    J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medullary carcinoma of the thyroid and 99mTc(V)-DMSA scintigraphy. Clinical results with a new radiopharmaceutical].
    Kujat C; Neidl K; Müller-Leisse C
    Rofo; 1990 Nov; 153(5):495-500. PubMed ID: 2173051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.
    Hilditch TE; Connell JM; Elliot AT; Murray T; Reed NS
    J Nucl Med; 1986 Jul; 27(7):1150-3. PubMed ID: 3014086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
    Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ
    J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
    Ohta H; Endo K; Fujita T; Koizumi M; Konishi J; Maki A; Mori K; Ozawa K; Inoue G; Nakano Y
    J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of 99mTc(V)-dimercapto succinic acid (DMSA) for imaging medullary carcinoma of thyroid and its metastasis.
    Patel MC; Patel RB; Ramanathan P; Ramamoorthy N; Krishna BA; Sharma SM
    Eur J Nucl Med; 1988; 13(10):507-10. PubMed ID: 2836203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of 99mTc(V)-DMSA complex: studies in medullary carcinoma of thyroid.
    Ramamoorthy N; Shetye SV; Pandey PM; Mani RS; Patel MC; Patel RB; Ramanathan P; Krishna BA; Sharma SM
    Eur J Nucl Med; 1987; 12(12):623-8. PubMed ID: 3034614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of radiopharmaceuticals MIBG and (V) DMSA in the diagnosis of medullary thyroid carcinoma.
    Verga U; Muratori F; Di Sacco G; Banfi F; Libroia A
    Henry Ford Hosp Med J; 1989; 37(3-4):175-7. PubMed ID: 2576958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTc(V)-dimercaptosuccinic acid scintigraphy for medullary thyroid carcinoma.
    Miyauchi A; Endo K; Ohta H; Torizuka K; Matsuzuka F; Kobayashi A; Kuma K; Maeda M
    World J Surg; 1986 Aug; 10(4):640-5. PubMed ID: 3019022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.